secwatch.observer — SEC 8-K summary
======================================

Issuer:     ArriVent BioPharma, Inc. (AVBP)
CIK:        0001868279
Form:       8-K
Filed at:   2025-06-20T23:59:59+00:00
Accession:  0001104659-25-061165
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

ArriVent shareholders elect Yao and Peterson to board, ratify PwC as auditor
----------------------------------------------------------------------------

- Quorum of 73.89% (25.2M shares) present at June 18 annual meeting.
- Zhengbin Yao elected with 22.1M for vs 0.4M withheld; broker non-votes 2.6M.
- Kristine Peterson elected with 21.9M for vs 0.6M withheld; broker non-votes 2.6M.
- Ratification of PwC as FY2025 auditor: 25.0M for, 242 against, 167.5K abstain.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1868279/000110465925061165/0001104659-25-061165-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1868279/000110465925061165/tm2518556d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-061165

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer